Me too - I loved the polymedix asset purchase from the beginning - Brilacidin will likely take us to double digits first, but also in agreement with notrichyet - Kevetrin has the speculative potential to push us to triple digits and the revenue potential if it works as intended to keep us there. Of course Brilacidin and its derivatives might also have triple digit potential...

Good to see some more activity here!!!